|
1
|
Van Cutsem E, Sagaert X, Topal B,
Haustermans K and Prenen H: Gastric cancer. Lancet. 388:2654–2664.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye J, Xu J, Li Y, Huang Q, Huang J, Wang
J, Zhong W and Lin X, Chen W and Lin X: DDAH1 mediates gastric
cancer cell invasion and metastasis via Wnt/β-catenin signaling
pathway. Mol Oncol. 11:1208–1224. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harris AM, Warner BW, Wilson JM, Becker A,
Rowland RG, Conner W, Lane M, Kimbler K, Durbin EB, Baron AT and
Kyprianou N: Effect of alpha1-adrenoceptor antagonist exposure on
prostate cancer incidence: An observational cohort study. J Urol.
178:2176–2180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Algazi M, Plu-Bureau G, Flahault A, Dondon
MG and Le MG: Is beta-blocker treatment associated with a decrease
in the risk of cancer. Lett Drug Des Discov. 3:653–661. 2006.
View Article : Google Scholar
|
|
6
|
Entschladen F, Drell TL IV, Lang K, Joseph
J and Zaenker KS: Tumour-cell migration, invasion, and metastasis:
Navigation by neurotransmitters. Lancet Oncol. 5:254–258. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Entschladen F, Drell TL IV, Lang K, Joseph
J and Zaenker KS: Neurotransmitters and chemokines regulate tumor
cell migration: Potential for a new pharmacological approach to
inhibit invasion and metastasis development. Curr Pharm Des.
11:403–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lang K, Drell TL IV, Lindecke A, Niggemann
B, Kaltschmidt C, Zaenker KS and Entschladen F: Induction of a
metastatogenic tumor cell type by neurotransmitters and its
pharmacological inhibition by established drugs. Int J Cancer.
112:231–238. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dorn GW II and Liggett SB:
Pharmacogenomics of beta-adrenergic receptors and their accessory
signaling proteins in heart failure. Clin Transl Sci. 1:255–262.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rosini M, Bolognesi ML, Giardina D,
Minarini A, Tumiatti V and Melchiorre C: Recent advances in
alpha1-adrenoreceptor antagonists as pharmacological tools and
therapeutic agents. Curr Top Med Chem. 7:147–162. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hein P and Michel MC: Signal transduction
and regulation: Are all alpha1-adrenergic receptor subtypes created
equal? Biochem Pharmacol. 73:1097–1106. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Docherty JR: Subtypes of functional
alpha1-adrenoceptor. Cell Mol Life Sci. 67:405–417. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hubbard KB and Hepler JR: Cell signalling
diversity of the Gqalpha family of heterotrimeric G proteins. Cell
Signal. 18:135–150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Theroux TL, Esbenshade TA, Peavy RD and
Minneman KP: Coupling efficiencies of human alpha 1-adrenergic
receptor subtypes: Titration of receptor density and responsiveness
with inducible and repressible expression vectors. Mol Pharmacol.
50:1376–1387. 1996.PubMed/NCBI
|
|
15
|
Fitzgerald PJ: Is norepinephrine an
etiological factor in some types of cancer? Int J Cancer.
124:257–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adissu HA and Schuller HM: Antagonistic
growth regulation of cell lines derived from human lung
adenocarcinomas of Clara cell and aveolar type II cell lineage:
Implications for chemoprevention. Int J Oncol. 24:1467–1472.
2004.PubMed/NCBI
|
|
17
|
Gobbi PG, Villano L, Pozzoli D, Bergonzi
M, Vanoli A, Tava F, Dionigi P and Corazza GR: Improving the
AJCC/TNM classification for use in early gastric cancer. J
Gastrointest Surg. 15:935–941. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
In H, Solsky I, Palis B, Langdon-Embry M,
Ajani J and Sano T: Validation of the 8th edition of the AJCC TNM
staging system for gastric cancer using the national cancer
database. Ann Surg Oncol. 24:3683–3691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX and Wang XW: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roessler S, Long EL, Budhu A, Chen Y, Zhao
X, Ji J, Walker R, Jia HL, Ye QH, Qin LX, et al: Integrative
genomic identification of genes on 8p associated with
hepatocellular carcinoma progression and patient survival.
Gastroenterology. 142:957–966.e12. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shaul YD, Yuan B, Thiru P, Nutter-Upham A,
McCallum S, Lanzkron C, Bell GW and Sabatini DM: MERAV: A tool for
comparing gene expression across human tissues and cell types.
Nucleic Acids Res. 44(D1): D560–D566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Anaya J: OncoLnc: Linking TCGA survival
data to mRNAs, miRNAs, and lncRNAs. PeerJ Comp Sci. 2:e672016.
View Article : Google Scholar
|
|
23
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38:W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mínguez B, Hoshida Y, Villanueva A,
Toffanin S, Cabellos L, Thung S, Mandeli J, Sia D, April C, Fan JB,
et al: Gene-expression signature of vascular invasion in
hepatocellular carcinoma. J Hepatol. 55:1325–1331. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Magnon C, Hall SJ, Lin J, Xue X, Gerber L,
Freedland SJ and Frenette PS: Autonomic nerve development
contributes to prostate cancer progression. Science.
341:12363612013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schuller HM: Neurotransmitter
receptor-mediated signaling pathways as modulators of
carcinogenesis. Prog Exp Tumor Res. 39:45–63. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thaker PH, Han LY, Kamat AA, Arevalo JM,
Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori
M, et al: Chronic stress promotes tumor growth and angiogenesis in
a mouse model of ovarian carcinoma. Nat Med. 12:939–944. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wan D, Gong Y, Qin W, Zhang P, Li J, Wei
L, Zhou X, Li H, Qiu X, Zhong F, et al: Large-scale cDNA
transfection screening for genes related to cancer development and
progression. Proc Natl Acad Sci USA. 101:15724–15729. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li J, Yang XM, Wang YH, Feng MX, Liu XJ,
Zhang YL, Huang S, Wu Z, Xue F, Qin WX, et al: Monoamine oxidase A
suppresses hepatocellular carcinoma metastasis by inhibiting the
adrenergic system and its transactivation of EGFR signaling. J
Hepatol. 60:1225–1234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Perez DM: The adrenergic receptors: In the
21st century. NewYork: Humana Press; 2006
|
|
32
|
Liu W, Wang X, Mei Z, Gong J, Huang L, Gao
X, Zhao Y, Ma J and Qian L: BNIP3L promotes cardiac fibrosis in
cardiac fibroblasts through [Ca2+]i-TGF-β-Smad2/3
pathway. Sci Rep. 7:19062017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Oganesian A, Yarov-Yarovoy V, Parks WC and
Schwinn DA: Constitutive coupling of a naturally occurring human
alpha1a- adrenergic receptor genetic variant to EGFR
transactivation pathway. Proc Natl Acad Sci USA. 108:19796–19801.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Salazar R and Ciardiello F: Optimizing
anti-EGFR therapy in colorectal cancer. Clin Cancer Res.
21:5415–5416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
García-Cazarín ML, Smith JL, Clair DK and
Piascik MT: The alpha1D-adrenergic receptor induces vascular smooth
muscle apoptosis via a p53-dependent mechanism. Mol Pharmacol.
74:1000–1007. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Okada H and Mak TW: Pathways of apoptotic
and non-apoptotic death in tumour cells. Nat Rev Cancer. 4:592–603.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu B, Chen Y and St Clair DK: Ros and
p53: A versatile partnership. Free Radic Biol Med. 44:1529–1535.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xiao L, Pimentel DR, Wang J, Singh K,
Colucci WS and Sawyer DB: Role of reactive oxygen species and
NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat
cardiac myocytes. Am J Physiol Cell Physiol. 282:C926–C934. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yoda Y, Takeshima H, Niwa T, Kim JG, Ando
T, Kushima R, Sugiyama T, Katai H, Noshiro H and Ushijima T:
Integrated analysis of cancer-related pathways affected by genetic
and epigenetic alterations in gastric cancer. Gastric Cancer.
18:65–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Z, Wang W, Xu S, Wang S, Tu Y, Xiong
Y, Mei J and Wang C: The role of MAPK signaling pathway in the
Her-2-positive meningiomas. Oncol Rep. 36:685–695. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schwappacher R, Rangaswami H, Su-You J,
Hassad A, Spitler R and Casteel DE: cGMP-dependent protein kinase
Iβ regulates breast cancer cell migration and invasion via
interaction with the actin/myosin-associated protein caldesmon. J
Cell Sci. 126:1626–1636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu S, Sun L, Jiao Y and Lee LTO: The role
of G protein-coupled receptor kinases in cancer. Int J Biol Sci.
14:189–203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Peng L, Peng W, Hu P and Zhang HF:
Clinical significance of expression levels of serum ADRA1A in
hysterocarcinoma patients. Oncol Lett. 15:9162–9166.
2018.PubMed/NCBI
|
|
44
|
Powe DG, Voss MJ, Habashy HO, Zänker KS,
Green AR, Ellis IO and Entschladen F: Alpha- and beta-adrenergic
receptor (AR) protein expression is associated with poor clinical
outcome in breast cancer: An immunohistochemical study. Breast
Cancer Res Treat. 130:457–463. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang JJ and Blobe GC: Dichotomous roles
of TGF-β in human cancer. Biochem Soc Trans. 44:1441–1454. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Costanza B, Umelo IA, Bellier J,
Castronovo V and Turtoi A: Stromal modulators of TGF-β in cancer. J
Clin Med. 6(pii): E72017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tatsuta M, Iishi H, Baba M, Yano H, Sakai
N, Uehara H, Hirasawa R and Nakaizumi A: Alpha1-adrenoceptor
stimulation enhances experimental gastric carcinogenesis induced by
N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer.
77:467–469. 1998. View Article : Google Scholar : PubMed/NCBI
|
